Edward J. Zecchini is Director at Cryoport, Inc. (CYRX). They have made 12 open-market trades across 1 company since 2020, most recently 2026-06-11.
CIK 0001587502
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CYRX | 109,719 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2026-06-12 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CYRX | SELL | 2026-06-10 | 2026-06-12 | $14.50 | $508K | +6.7% | +5.6% | +2.6% |
| CYRX | SELL | 2026-03-16 | 2026-03-17 | $8.00 | $16K | -7.1% | +20.8% | +75.6% |
| CYRX | SELL | 2025-06-10 | 2025-06-10 | $6.85 | $353K | -3.4% | +10.6% | +47.9% |
| CYRX | SELL | 2025-03-17 | 2025-03-18 | $6.29 | $7K | -1.5% | -10.3% | +12.1% |
| CYRX | SELL | 2024-05-14 | 2024-05-15 | $13.37 | $46K | -20.9% | -30.0% | -41.6% |
| CYRX | SELL | 2021-07-01 | 2021-07-06 | $62.74 | $627K | -10.5% | +6.4% | +0.9% |
| CYRX | SELL | 2021-06-10 | 2021-06-11 | $59.11 | $493K | +7.2% | -0.6% | +2.6% |
| CYRX | SELL | 2021-05-13 | 2021-05-17 | $51.50 | $558K | +9.9% | +20.3% | +12.1% |
| CYRX | SELL | 2021-04-08 | 2021-04-09 | $52.17 | $445K | +0.5% | +4.8% | +15.1% |
| CYRX | SELL | 2021-03-11 | 2021-03-12 | $55.65 | $464K | -15.9% | -13.1% | +1.4% |
| CYRX | SELL | 2020-05-13 | 2020-05-14 | $23.42 | $390K | +5.4% | +12.9% | +35.3% |
| CYRX | SELL | 2020-03-11 | 2020-03-18 | $17.27 | $181K | +16.2% | +13.2% | +83.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.